These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
508 related items for PubMed ID: 10771110
1. The effect of intrastriatal single injection of GDNF on the nigrostriatal dopaminergic system in hemiparkinsonian rats: behavioral and histological studies using two different dosages. Aoi M, Date I, Tomita S, Ohmoto T. Neurosci Res; 2000 Apr; 36(4):319-25. PubMed ID: 10771110 [Abstract] [Full Text] [Related]
2. Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats. Tang FI, Tien LT, Zhou FC, Hoffer BJ, Wang Y. Exp Brain Res; 1998 Apr; 119(3):287-96. PubMed ID: 9551829 [Abstract] [Full Text] [Related]
3. Single or continuous injection of glial cell line-derived neurotrophic factor in the striatum induces recovery of the nigrostriatal dopaminergic system. Aoi M, Date I, Tomita S, Ohmoto T. Neurol Res; 2000 Dec; 22(8):832-6. PubMed ID: 11149247 [Abstract] [Full Text] [Related]
4. Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle. Rosenblad C, Kirik D, Devaux B, Moffat B, Phillips HS, Björklund A. Eur J Neurosci; 1999 May; 11(5):1554-66. PubMed ID: 10215908 [Abstract] [Full Text] [Related]
5. Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor. Kirik D, Rosenblad C, Björklund A. Eur J Neurosci; 2000 Nov; 12(11):3871-82. PubMed ID: 11069582 [Abstract] [Full Text] [Related]
6. GDNF triggers fiber outgrowth of fetal ventral mesencephalic grafts from nigra to striatum in 6-OHDA-lesioned rats. Wang Y, Tien LT, Lapchak PA, Hoffer BJ. Cell Tissue Res; 1996 Nov; 286(2):225-33. PubMed ID: 8854891 [Abstract] [Full Text] [Related]
7. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model. Rosenblad C, Kirik D, Björklund A. Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072 [Abstract] [Full Text] [Related]
8. Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer. Georgievska B, Kirik D, Björklund A. Exp Neurol; 2002 Oct; 177(2):461-74. PubMed ID: 12429192 [Abstract] [Full Text] [Related]
9. Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Wang JY, Wu JN, Cherng TL, Hoffer BJ, Chen HH, Borlongan CV, Wang Y. Brain Res; 2001 Jun 15; 904(1):67-75. PubMed ID: 11516412 [Abstract] [Full Text] [Related]
10. GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Kearns CM, Gash DM. Brain Res; 1995 Feb 20; 672(1-2):104-11. PubMed ID: 7749731 [Abstract] [Full Text] [Related]
11. Intrastriatal injection of GDNF attenuates the effects of 6-hydroxydopamine. Shults CW, Kimber T, Martin D. Neuroreport; 1996 Jan 31; 7(2):627-31. PubMed ID: 8730845 [Abstract] [Full Text] [Related]
12. In vivo microdialysis studies on somatodendritic dopamine release in the rat substantia nigra: effects of unilateral 6-OHDA lesions and GDNF. Hoffman AF, van Horne CG, Eken S, Hoffer BJ, Gerhardt GA. Exp Neurol; 1997 Sep 31; 147(1):130-41. PubMed ID: 9294410 [Abstract] [Full Text] [Related]
14. Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: comparison of intraventricular and intranigral delivery. Lapchak PA, Miller PJ, Collins F, Jiao S. Neuroscience; 1997 May 31; 78(1):61-72. PubMed ID: 9135089 [Abstract] [Full Text] [Related]
15. GDNF partially protects grafted fetal dopaminergic neurons against 6-hydroxydopamine neurotoxicity. Yurek DM, Fletcher-Turner A. Brain Res; 1999 Oct 16; 845(1):21-7. PubMed ID: 10529440 [Abstract] [Full Text] [Related]
16. Intrastriatal glial cell line-derived neurotrophic factor promotes sprouting of spared nigrostriatal dopaminergic afferents and induces recovery of function in a rat model of Parkinson's disease. Rosenblad C, Martinez-Serrano A, Björklund A. Neuroscience; 1998 Jan 16; 82(1):129-37. PubMed ID: 9483509 [Abstract] [Full Text] [Related]
17. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections. Kozlowski DA, Connor B, Tillerson JL, Schallert T, Bohn MC. Exp Neurol; 2000 Nov 16; 166(1):1-15. PubMed ID: 11031079 [Abstract] [Full Text] [Related]
18. Adenoviral vector-mediated GDNF gene therapy in a rodent lesion model of late stage Parkinson's disease. Lapchak PA, Araujo DM, Hilt DC, Sheng J, Jiao S. Brain Res; 1997 Nov 28; 777(1-2):153-60. PubMed ID: 9449424 [Abstract] [Full Text] [Related]
19. Involvement of GDNF in neuronal protection against 6-OHDA-induced parkinsonism following intracerebral transplantation of fetal kidney tissues in adult rats. Borlongan CV, Zhou FC, Hayashi T, Su TP, Hoffer BJ, Wang Y. Neurobiol Dis; 2001 Aug 28; 8(4):636-46. PubMed ID: 11493028 [Abstract] [Full Text] [Related]
20. Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivo. Sullivan AM, Opacka-Juffry J, Blunt SB. Eur J Neurosci; 1998 Jan 28; 10(1):57-63. PubMed ID: 9753113 [Abstract] [Full Text] [Related] Page: [Next] [New Search]